Product NDC: | 0024-5824 |
Proprietary Name: | Jevtana |
Non Proprietary Name: | cabazitaxel |
Active Ingredient(s): | & nbsp; cabazitaxel |
Administration Route(s): | |
Dosage Form(s): | KIT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0024-5824 |
Labeler Name: | Sanofi-Aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA201023 |
Marketing Category: | NDA |
Start Marketing Date: | 20100617 |
Package NDC: | 0024-5824-11 |
Package Description: | 1 KIT in 1 CARTON (0024-5824-11) * 5.7 mL in 1 VIAL, GLASS (0024-5823-15) * 5.7 mL in 1 VIAL, GLASS (0024-5822-01) |
NDC Code | 0024-5824-11 |
Proprietary Name | Jevtana |
Package Description | 1 KIT in 1 CARTON (0024-5824-11) * 5.7 mL in 1 VIAL, GLASS (0024-5823-15) * 5.7 mL in 1 VIAL, GLASS (0024-5822-01) |
Product NDC | 0024-5824 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cabazitaxel |
Dosage Form Name | KIT |
Route Name | |
Start Marketing Date | 20100617 |
Marketing Category Name | NDA |
Labeler Name | Sanofi-Aventis U.S. LLC |
Substance Name | |
Strength Number | |
Strength Unit | |
Pharmaceutical Classes |